BioSpace News Archive

The demand for nitric oxide gas has been increasing over the last few years due to its wide use in the healthcare sector.

Rise in proteomics research and development of novel methods opened up new avenues for protein therapeutics.

The Company applied for a Dealer’s License from Health Canada in July of 2021.

LifeNet Health LifeSciences, a leader in all-human biomedical research solutions, will showcase a unique new triculture system during the Society of Toxicology Annual Meeting and ToxExpo in San Diego, March 27-31.

Iridex Corporation, a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, announced the appointment of Beverly Huss to its board of directors, effective, March 17, 2022.

TELA Bio, Inc. today reported financial results for the fourth quarter and full year ended December 31, 2021.

AVITA Medical, Inc. announced that the Biomedical Advanced Research and Development Authority has modified its existing contract with the Company to support AVITA Medical’s clinical trial in soft tissue reconstruction.

Viridian Therapeutics, Inc. announced that it has dosed the first subject in a Phase 1 clinical trial evaluating VRDN-002 for the treatment of thyroid eye disease.

This week at the Drug, Chemical & Associated Technologies Association (DCAT) conference in New York, NY, Thermo Fisher Scientific will highlight its investments and innovation across its global pharma services network from development to commercial.

AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on emerging immune control mechanisms applicable to inflammation and immuno-oncology indications, today announced the appointment of Daniel Faga as interim president and chief executive officer (CEO), effective immediately.